First Header Logo Second Header Logo

Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes.

Il'yasova D, Morrow JD, Wagenknecht LE. Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes Res. 2005 Sep; 13(9):1638-44.

View in: PubMed